Pharma & Biotech

NuCana plc witnessed a significant sell-off on Thursday, with its shares plunging 7.92 percent to close at $3.49. This sharp...

The biotech sector has a new standout performer, yet BridgeBio Pharma's remarkable surge conceals a troubling divergence. As clinical trial...

Equillium shares posted significant gains in today's trading session following the release of encouraging quarterly figures and the announcement of...

The German biotech firm BioNTech finds itself navigating turbulent waters following a significant divestment by its longtime collaborator. In a...

In a surprising market development, Relmada Therapeutics witnessed its stock value drop by more than 3% during premarket trading. This...

The biotechnology sector is witnessing the emergence of a standout performer as Alnylam demonstrates remarkable momentum. The company is not...

The recent quarterly report from Protara Therapeutics presents investors with a curious market puzzle. Despite posting financial results that surpassed...

Shares of Aclaris Therapeutics are demonstrating significant upward momentum, propelled by a confluence of positive clinical developments and robust financial...

Scilex shareholders are bracing for significant volatility as two major corporate events converge this week, each possessing the potential to...

While Globus Medical showcases exceptional financial performance with record-breaking results and elevated guidance, company directors are simultaneously executing multi-million dollar...